WHO ICTRP trial
EUCTR2014-003484-38-FR · ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
EUCTR2014-003484-38-FR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2014-003484-38-FR |
|---|---|
| Scientific title | N/A - TIDOA |
| Primary sponsor | ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | France |
| Conditions | MedDRA version: 18.0 Level: LLT Classification code 10016686 Term: Finger osteoarthritis System Organ Class: 100000004859 ;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05] |
| Interventions | Trade Name: Roche Registration Limited Product Name: RoActemra Product Code: EMEA/H/C/000955 Pharmaceutical Form: Concentrate for solution for injection INN or Proposed INN: tocilizumab CAS Number: 375823-41-9 Concentration unit: mg/ml… |
| Registration date | Jun 19, 2015 |
| Target size | 90 |
| Secondary IDs | P120206 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: